Quantitative systems pharmacology (QSP) modeling enables better drug development decisions through a more advanced understanding of the disease area of interest.
This webinar will include:
- Predictions of exposure at the relevant site of action through PBPK (GastroPlus®) and machine learning (ADMET Predictor®) techniques
- Discussion on the importance of population-level variability and special population considerations (SimPops)
- Real-world questions that we have helped the pharmaceutical industry address within QSP projects
- Live Q&A session
Kyunghee Yang, Principal Scientist, DILIsym Services
Viera Lukacova, Chief Scientist, Simulations Plus, Inc.
Scott Siler, Chief Scientific Officer, DILIsym Services
Brett Howell, Divisional President, DILIsym Services